Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Canadian researchers called to contribute to the national and global COVID-19 response

Date added: 05 May 2020

The funding for rapid research in a variety of fields responding to the current phase of COVID-19 pandemic in Canada and around the globe, which is focused on slowing and stopping the spread of the virus.

Amount
C$107.9M
Agency or Funder
Canadian Institutes of Health Research
Eligibility (if available)

The principal applicant must be an independent researcher appointed at a CIHR eligible institution. Some projects require collaboration with an institution in a low- to middle-income country.

Foreign participation? (where known)
Yes
Date application deadline

Swiss national COVID-19 research programme

Date added: 08 May 2020

Projects must advance the understanding of COVID-19 and the development of vaccines, therapeutics, and diagnostics. Multidisciplinary collaborations and use of international research networks are encouraged.

Amount
CHF 20M
Agency or Funder
Swiss National Science Foundation
Eligibility (if available)

Independent researchers holding a PhD or equivalent

Foreign participation? (where known)
Yes
Date application deadline

Binational projects based in the University of Mexico or the University of California

Date added: 27 Apr 2020

A call for binational collaborative innovation, product development, and applied research that aims to mitigate the health, social, and economic impacts of the COVID-19 pandemic.
Funding available in two stages: $10,000 and $25,000.

Amount
$35.000 (U.S. dollars)
Agency or Funder
National Autonomous University of Mexico, University of California, Ministry of Foreign Affairs of Mexico
Eligibility (if available)

Any active member of UC or UNAM (faculty, students, staff, visiting scholars, fellows, etc). Non-faculty researchers must identify a faculty mentor from their institution.

Foreign participation? (where known)
No
Date application deadline

Understanding the pathobiology and clinical implications of SARS-CoV-2

Date added: 29 Apr 2020

Proposals may address the biology of respiratory viruses, epidemiological approaches to them, development of novel therapeutics and vaccines, deciding host factors and individual, regional, or social factors affecting community spread of COVID-19.

Amount
$100.000 (U.S. dollars) per year, for up to two years
Agency or Funder
American Lung Association
Eligibility (if available)

Applicants must hold a PhD and work in a non-profit academic institution

Date application deadline

MRFF – 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity

Date added: 23 Apr 2020

Proposals sought for a clinical trial that accelerates the implementation of treatments for severe acute respiratory distress in patients infected with COVID-19 in order to support the response to the COVID-19 outbreak in Australia.

Amount
$5M AUD
Agency or Funder
Australian National Health and Medical Research Council (NHMRC)
Eligibility (if available)

Applications will only be accepted from NHMRC approved Administering Institutions

Date application deadline

Free transnational access to high-containment facilities

Date added: 19 Jun 2020

Researchers investigating COVID-19 can get free access to high-containment research facilities, resources and services across Europe.

Amount
Access to high containment facilities
Agency or Funder
The European Research Infrastructure on Highly pathogenic Agents
Eligibility (if available)

Researchers or teams of researchers from anywhere

Foreign participation? (where known)
Yes
Date application deadline

Free transnational access to high containment facilities

Date added: 15 Jun 2020

Researchers investigating COVID-19 can get free access to high containment research facilities, resources and services across Europe.

Amount
Access to high containment facilities
Agency or Funder
The European Research Infrastructure on Highly pathogenic Agents
Eligibility (if available)

Researchers or teams of researchers from anywhere

Foreign participation? (where known)
Yes
Date application deadline

Funding support for clinical trials

Date added: 05 May 2020

Funding for clinical trials to evaluate new drugs, devices, clinical guidance, approaches and technologies aimed at stopping the spread of COVID-19. Projects may range from proof-of-concept to large-scale trials.

Amount
$30M (U.S.)
Agency or Funder
US Army Medical Research Acquisition Activity
Eligibility (if available)

Principal investigator must be at level of Assistant Professor or equivalent.

Foreign participation? (where known)
Yes
Date application deadline

Amazon Web Services offers its customers support to find diagnostic solutions

Date added: 23 Apr 2020

Support for innovation in rapid and accurate patient testing for the novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks.

Amount
$20M (U.S dollars)
Agency or Funder
Amazon Web Services (AWS)
Eligibility (if available)

Research institutions, research consortia, and private entities that are AWS customers. Individuals must apply on behalf of their organization and not in their personal capacity.

Foreign participation? (where known)
Yes
Date application deadline

An urgent call for proposals for assays, vaccines, disease models and advanced manufacturing techniques.

Date added: 23 Apr 2020

BARDA is seeking abstract submissions for the following: Diagnostic assays, screening and model development, vaccines, advanced manufacturing.

Amount
$750,000 (U.S dollars)
Agency or Funder
Biomedical Advanced Research and Development Authority (BARDA)
Eligibility (if available)

Not specified, but a call with the relevant Program Manager is strongly encouraged.

Date application deadline

Preparing for future high-impact pandemics

Date added: 20 May 2020

Research or innovation projects should enhance public preparedness for upcoming pandemics with medical, surveillance, sanitation, supply chain, education, and other technologies.

Agency or Funder
Eureka
Eligibility (if available)

At least two organisations from at least two of the following countries: Belgium, Canada, Estonia, Finland, France, the Netherlands, South Africa, Spain, Sweden, Turkey. Organisations from other Eureka countries can also participate

Foreign participation? (where known)
Yes
Date application deadline

New COVID-19 funding call for vaccines to be deployed rapidly

Date added: 08 May 2020

CEPI is looking for proposals for the development of vaccines that can be accepted and deployed within 12-18 months or less.

Amount
Unspecified
Agency or Funder
The Coalition for Epidemic Preparedness Innovations
Eligibility (if available)

Any organisation developing a COVID-19 vaccine

Foreign participation? (where known)
Yes
Date application deadline

Funding for research into mechanisms of immunoregulation

Date added: 23 Apr 2020

Grants to identify key immune regulatory genes, signaling pathways, or mechanisms to contribute to the knowledge of the pathogenesis of infectious diseases.

Amount
$275,000 (for two- year project)
Agency or Funder
National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility (if available)

Higher Education Institutions, Nonprofits and For-Profit Organizations,State Governments ini the US.

Date application deadline

Aiding industrial competitiveness through R&D in COVID-19 technologies

Date added: 12 May 2020

Projects must combine industrial and research partners and be focused on therapeutics and technologies.

Amount
Minimum of €4M, maximum of €50M (or potentially more)
Agency or Funder
Ministry of Higher Education and Research, and Bpifrance
Eligibility (if available)

Research teams must be based on a partnership between industrial and research actors

Date application deadline

Broad opportunities for research funding related to COVID-19

Date added: 23 Apr 2020

BARDA is looking to help the development of products to diagnose, prevent or treat novel coronavirus infections. (BARDA will only accept submissions related to the SARS-CoV-2 virus or the COVID-19 disease until further notice.)

Amount
Unlimited
Agency or Funder
Biomedical Advanced Research and Development Authority (BARDA)
Eligibility (if available)

Single entities or teams from private sector organizations, Government laboratories, and academic institutions.

Date application deadline

NIAID’s Multi-Pronged Response to the COVID-2019 Outbreak

Date added: 23 Apr 2020

Research in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-2019).

Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID
Eligibility (if available)

Grantees currently supported by active NIH (National Institute of Allergy and Infectius Diseases) funding

Date application deadline

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)

Date added: 23 Apr 2020

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID & NIGMS
Eligibility (if available)

Existing grantholders wishing to expand the scope of their research.

Foreign participation? (where known)
Yes
Date application deadline

Emergency competitive revisions for research on SARS-CoV-2 and COVID-19

Date added: 23 Apr 2020

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility (if available)

Existing NIAID grantholders

Date application deadline